EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

CRF Bracket Supports Remote Consenting for Virtual Clinical Studies with Latest Release of its Integrated eConsent Solution

TrialConsent extends informed consent to virtual studies for Sites, Sponsors and Patients London, UK and Philadelphia, USA – March 19, 2019:  CRF Bracket anno...
Continue Reading →
news

The flow diversion stent market is growing at a CAGR of approximately 2%, says GlobalData

Estimated to be approximately 15% of the embolization devices market, the flow diversion stent market is growing at a Compound Annual Growth Rate (CAGR) of approxima...
Continue Reading →
news

Phase III failure for Pollinex Quattro Birch puts Allergy Therapeutics in a precarious position for long-awaited US expansion, says GlobalData

On 18 March 2019, Allergy Therapeutics announced that its Phase III pivotal trial for Pollinex Quattro (PQ) Birch, an ultra-short course birch pollen allergen immuno...
Continue Reading →
Europe

SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer

DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62%Overall survival (OS) increased significantly by 13.4 months. Median Pro...
Continue Reading →
Asia Pacific

FDA Green-Lights Two Therapies, While Late-Stage Successes Set Stage for Potential Approvals

The U.S. Food and Drug Administration (FDA) has been busy approving new treatments for various diseases. Two days into the new week and the regulatory agency has gre...
Continue Reading →
news

New drug may stop sepsis from reaching major organs

Researchers discover a drug that has the potential to stop sepsis before the condition reaches major organs and becomes fatal. A new preclinical trial of a sep...
Continue Reading →
news

New brain stimulation therapy is effective against depression

A new clinical trial has tested the ability of a little-studied, noninvasive brain stimulation technique to treat the symptoms of major depression. The results, so ...
Continue Reading →
news

Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

Novo Nordisk announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was t...
Continue Reading →
Europe

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWA...
Continue Reading →
Australasia

PCI Pharma Services Announces Appointment of Lisa Spence as Director of Clinical Supply Chain – International Region

Philadelphia, PA – March 12, 2019. Leading biopharmaceutical services provider PCI Clinical Services (PCI) is pleased to announce the appointment of Lisa Spence...
Continue Reading →
Quotient